Clinical Trial: Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Glioblastoma
Study Type: INTERVENTIONAL
Official Title: A Randomized, Open-label, Multicentric, Two-arm Pivotal Trial of SonoCloud-9 Combined With Carboplatin (CBDCA) vs Standard of Care Lomustine (CCNU) or Temozolomide (TMZ) in Patients Undergoing Planned
Brief Summary:
The brain is protected from any toxic or inflammatory molecule by the blood-brain barrier (BBB).This physical barrier is located at the level of the blood vessel walls.Because of these barrier properties, the blood vessels are also impermeable to the passage of therapeutic molecules from the blood to the brain.The development of effective treatments against glioblastoma is thus limited due to the BBB that prevents most drugs injected in the bloodstream from getting into brain tissue where the tumour is seated.The…
Read more